Relieving select symptoms of the elderly.
D000367:Age Factors; D000368:Aged; D001008:Anxiety Disorders / Q000150:complications; D001290:Attitude; D001921:Brain / Q000187:drug effects; D002986:Clinical Trials as Topic; D003704:Dementia / Q000150:complications / Q000188:drug therapy*; D004088:Dihydroergotoxine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008019:Life Style; D008297:Male; D008569:Memory Disorders / Q000150:complications; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D013997:Time Factors
D010919:Placebos; D004088:Dihydroergotoxine; D004877:Ergoloid Mesylates; D010208:Papaverine